RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

More than 22,000 newborn babies received immunisation against RSV this winter as part of a pilot HSE programme to combat the ...

Discover a study that highlights the importance of identifying high-risk children through biomarkers and better understanding ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

In response to the global burden of severe respiratory syncytial virus (RSV) disease among infants, the World Health ...

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...

These real-world results support the effectiveness of maternal RSV vaccination and could influence policy decisions in other ...

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.